Will Pricing Reform Spur Divestment of Off-Patent Brands in Japan? Next 3 Months Hold Key for Future Directions

By Reiji Anasako With a major pricing overhaul looming in April, drug makers in Japan are being urged to retool their business models and FY2018 budgets so as to adapt themselves to the anticipated changes. The past two years have...read more